EUVIMEDEUVIMED entdecken
Crossref

Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients—propensity score-matched analysis

Jaeyun Lee iD, Chan-Young Jung iD, Hyosang Kim iD, Hwa Jung Kim iD, Youngmin Ko iD, Hyunwook Kwon iD, Sung Shin iD, Young Hoon Kim iD, Su-Kil Park iD, Chung Hee Baek iD

Journal of Nephrology · 2024

DOI: 10.1007/s40620-024-01938-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Jaeyun Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-…. Hauptthemen laut MEDLINE: Kidney Transplantation, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists, Propensity Score. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARBs) can cause acute kidney injury under dehydratation or in hemodynamically unstable conditions. Regarding kidney transplantation (KT), the risk of using ACEi/ARBs before surgery is not well established. Therefore, we evaluated the clinical outcomes to determine the effect of preoperative use of ACEi/ARBs on KT. METHODS: We retrospectively collected 1187 patients who received living-donor KT between January 2017 and December 2021. We conducted a propensity score-matched analysis between the ACEi/ARB(+) and ACEi/ARB(-) groups and evaluated the effects of ACEi/ARBs on delayed graft function, post-KT renal function, hyperkalemia events, rejection, and graft survival. RESULTS: The ACEi/ARB(+) group showed a similar incidence of delayed graft function as the ACEi/ARB(-) group (1.8% vs. 1.0%, P = 0.362). The risk of delayed graft function was not upregulated in the ACEi/ARB(+) group after propensity score-matching (odds ratio: 0.50, 95% confidence interval (CI) 0.13-2.00). Postoperative creatinine levels and the slope of creatinine levels after KT also were not significantly different between the two groups (creatinine slope from POD#0 to POD#7: - 0.73 ± 0.35 vs. - 0.75 ± 0.32 mg/dL/day, P = 0.464). Hyperkalemia did not occur more often in the ACEi/ARB(+) group than in the ACEi/ARB(-) group during perioperative days. Rejection-free survival (P = 0.920) and graft survival (P = 0.621) were not significantly different between the two groups. CONCLUSIONS: In KT, the preoperative use of ACEi/ARBs did not significantly affect clinical outcomes including delayed graft function, postoperative renal function, hyperkalemia events, incidence of rejection, and graft survival rates compared to the patients who did not receive ACEi/ARBs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsPropensity ScoreDelayed Graft FunctionGraft SurvivalGraft RejectionHumansMaleFemaleRetrospective StudiesMiddle AgedAdultHyperkalemiaPreoperative Care

Stichwörter der Autor:innen

ACEi/ARBAcute Kidney InjuryGraft outcomesHyperkalemiaKidney Transplantation

Substanzen

Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
  • Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. bch393@amc.seoul.kr.

ORCID-Profile: Jaeyun Lee, Chan-Young Jung, Hyosang Kim, Hwa Jung Kim, Youngmin Ko, Hyunwook Kwon, Sung Shin, Young Hoon Kim, Su-Kil Park, Chung Hee Baek

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Lee, J., Jung, C. Y., Kim, H., Kim, H. J., Ko, Y., Kwon, H., Shin, S., Kim, Y. H., Park, S. K., & Baek, C. H. (2024). Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients—propensity score-matched analysis. Journal of Nephrology. https://doi.org/10.1007/s40620-024-01938-3

Vancouver

Lee J, Jung CY, Kim H, Kim HJ, Ko Y, Kwon H, et al. Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients—propensity score-matched analysis. Journal of Nephrology. 2024. doi:10.1007/s40620-024-01938-3

BibTeX
@article{Lee2024,
  author = {Lee, Jaeyun and Jung, Chan-Young and Kim, Hyosang and Kim, Hwa Jung and Ko, Youngmin and Kwon, Hyunwook and Shin, Sung and Kim, Young Hoon and Park, Su-Kil and Baek, Chung Hee},
  title = {Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients—propensity score-matched analysis},
  journal = {Journal of Nephrology},
  year = {2024},
  doi = {10.1007/s40620-024-01938-3}
}
Kostenlos starten →